Literature DB >> 11751733

Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.

R Joannides1, C Bizet-Nafeh, A Costentin, M Iacob, G Derumeaux, A Cribier, C Thuillez.   

Abstract

Reduced conduit arteries flow-dependent dilatation and altered compliance have been described during heart failure. However, the role of shear stress, the relation between endothelial dysfunction and mechanics, and the effect of chronic ACE inhibition on this relationship have not been investigated. The present study was designed to evaluate in heart failure patients the relationship between flow-dependent dilatation and radial artery mechanics at known shear stress levels and to assess the effect of chronic ACE inhibition. Sixteen stable congestive heart failure patients, who had never been treated with ACE inhibitors, participated in the study. Arterial pressure, cardiac output (bioimpedance), radial artery diameter (echo tracking) and flow (Doppler), total blood viscosity, and mean artery wall shear stress were assessed before and during a gradual increase in the forearm blood flow in response to gradual distal hand skin heating. Cross-sectional radial artery compliance and distensibility indexes were calculated at 34 degrees C, 40 degrees C, and 44 degrees C. The endothelium-independent vasodilatation was evaluated by use of glyceryl trinitrate. All parameters were assessed before and 24 hours after the last administration of perindopril (4 mg once daily) or placebo in a 2-month double-blind randomized study. Before treatment, there was no difference between the 2 groups for all parameters. After chronic ACE inhibition, systolic arterial pressure decreased at baseline from 126+/-11 to 118+/-10 mm Hg (P<0.05). During heating, the increase in diameter in response to shear stress was higher after ACE inhibition than after placebo (time/treatment interaction, P<0.05). Moreover, in contrast to placebo, at the same shear stress, there was a significant increase in compliance (3.23+/-0.79 x 10(-7) to 6.82+/-2.47 x 10(-7) m(2)/kPa, P<0.05) and distensibility (5.71+/-1.35 x 10(-3) to 8.87+/-1.88 x 10(-3)/kPa, P<0.05) during heating after ACE inhibition. The effect of glyceryl trinitrate did not change. The present study demonstrates that chronic administration of the ACE inhibitor perindopril increases the magnitude of the flow-dependent dilatation and restores the flow-dependent increase in compliance and distensibility of the radial artery evaluated at stable shear stress. In addition, the decrease in baseline systolic arterial pressure after ACE inhibitor suggests an associated increase in the distensibility of the proximal elastic conduit arteries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751733     DOI: 10.1161/hy1201.096529

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans?

Authors:  Joshua C Tremblay; Kyra E Pyke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 2.  The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches.

Authors:  Rachel D Simmons; Sandeep Kumar; Hanjoong Jo
Journal:  Arch Biochem Biophys       Date:  2015-12-11       Impact factor: 4.013

3.  Flow-mediated vasodilation in end-stage renal disease.

Authors:  Francis H Verbeke; Bruno Pannier; Alain P Guérin; Pierre Boutouyrie; Stephane Laurent; Gérard M London
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  Risk factors for femoral-to-radial artery pressure gradient after weaning from cardiopulmonary bypass: a historical cohort study.

Authors:  Ah Ran Oh; Kwan Young Hong; Jungchan Park; Sukyoung Her; Jong-Hwan Lee
Journal:  Can J Anaesth       Date:  2022-10-06       Impact factor: 6.713

5.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

Review 6.  Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects?

Authors:  Sumeska Thavarajah; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

7.  Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

Authors:  Cevad Sekuri; Ozgur Bayturan; Hakan Gocer; Talat Tavli; Ugur Kemal Tezcan
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

Review 8.  Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.

Authors:  Maria M Patarroyo Aponte; Gary S Francis
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

9.  Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.

Authors:  Aurore Danigo; Mohamad Nasser; Flavien Bessaguet; James Javellaud; Nicole Oudart; Jean-Michel Achard; Claire Demiot
Journal:  Cardiovasc Diabetol       Date:  2015-02-18       Impact factor: 9.951

10.  Central-radial artery pressure gradient after cardiopulmonary bypass is associated with cardiac function and may affect therapeutic direction.

Authors:  Jie Sun; Zhengnian Ding; Yanning Qian; Yong G Peng
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.